{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae H. pylori IgG",
        "LIAISON\u00ae H. pylori IgG Control Set"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K161139",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000463",
        "K132234"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LYR",
        "JJX",
        "JJQ"
    ],
    "Summary Letter Date": "April 15, 2016",
    "Summary Letter Received Date": "April 22, 2016",
    "Submission Date": "April 15, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Helicobacter pylori"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Indirect chemiluminescence immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control Set"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON\u00ae H. pylori IgG chemiluminescent immunoassay and control set for qualitative determination of IgG antibodies to H. pylori in human serum.",
    "Indications for Use Summary": "Qualitative determination of IgG antibodies to Helicobacter pylori in human serum from symptomatic adults as an aid in diagnosis of Helicobacter pylori infection, to be performed on the LIAISON\u00ae XL Analyzer; control set for monitoring assay performance.",
    "fda_folder": "Microbiology"
}